The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe said at the IP Dealmakers Forum that other companies are “lining up to do deals” and that universities’ endowment funds are interested in getting involved. Shore outlined why he believed these types of deals are here to stay
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Andrea Stone explains how her in-house experience gives her a unique perspective, and why Ballard Spahr’s combination with Lane Powell made it an ideal time to join
The England and Wales appeals court handed down its judgment just seven working days after hearing the trademark dispute involving pharma company Merck